Abstract

Neutrophils employ several mechanisms to restrict fungi, including the action of enzymes such as myeloperoxidase (MPO) or NADPH oxidase, and the release of neutrophil extracellular traps (NETs). Moreover, they cooperate, forming “swarms” to attack fungi that are larger than individual neutrophils. Here, we designed an assay for studying how these mechanisms work together and contribute to neutrophil's ability to contain clusters of live Candida. We find that neutrophil swarming over Candida clusters delays germination through the action of MPO and NADPH oxidase, and restricts fungal growth through NET release within the swarm. In comparison with neutrophils from healthy subjects, those from patients with chronic granulomatous disease produce larger swarms against Candida, but their release of NETs is delayed, resulting in impaired control of fungal growth. We also show that granulocyte colony-stimulating factors (GCSF and GM-CSF) enhance swarming and neutrophil ability to restrict fungal growth, even during treatment with chemical inhibitors that disrupt neutrophil function.

Neutrophils employ several mechanisms to control the growth of fungi, including enzymes, reactive oxygen species, extracellular traps, and formation of “swarms”. Here, Hopke et al. study how the different mechanisms work together, using an in vitro assay with human neutrophils and clusters of live Candida cells.

Details

Title
Neutrophil swarming delays the growth of clusters of pathogenic fungi
Author
Hopke Alex 1   VIAFID ORCID Logo  ; Scherer, Allison 2   VIAFID ORCID Logo  ; Kreuzburg Samantha 3   VIAFID ORCID Logo  ; Abers, Michael S 3 ; Zerbe, Christa S 3 ; Dinauer, Mary C 4 ; Mansour, Michael K 2   VIAFID ORCID Logo  ; Irimia, Daniel 1   VIAFID ORCID Logo 

 Massachusetts General Hospital, BioMEMS Resource Center, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Shriners Hospital for Children, Boston, USA (GRID:grid.415829.3) (ISNI:0000 0004 0449 5362) 
 Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Massachusetts General Hospital, Division of Infectious Diseases, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924) 
 National Institutes of Health (NIH), Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165) 
 Washington University School of Medicine in St. Louis, Departments of Pediatrics and of Pathology and Immunology, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2395249072
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.